Kezar Life Sciences Inc

Stocks Under $10 Biotech Stocks Healthcare Stocks

$7.40

-0.02 (-0.27%)

As of Apr 1, 10:10 PM ET ·

Analyst Consensus

Hold

Analysts

Moderate

Coverage

Buy 4 40%

Hold 6 60%

Sell 0 0%

Price Target

Analyst Price Target +154.2% upside

Low Target $12.87

Average Target $18.81

High Target $22.25

Current Price $7.40

Current
$7.40

Target
$18.81

$12.87 $18.81 avg $22.25

Scenario Analysis

Bear Case

$12.87

73.9%

Low target

Base Case

$18.81

+154.2%

Avg target

Bull Case

$22.25

+200.7%

High target

Risk/Reward

2.7x

Favorable

Price in Context

52-Week High

$7.45

-0.7% from high

52-Week Low

$3.53

+109.4% from low

Target vs 52W High

$18.81

+152.5% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+19.8%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.0%
GILD Gilead Sciences Inc	Strong Buy	38	79%	$362.68	+158.5%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-2.0%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.1%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-13.0%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-29.7%